CALR and essential thrombocythemia: One patient with long-standing Calreticulin (CALR)-mutated essential thrombocythemia (ET) later acquired a UBA1 mutation; the UBA1-mutant clone progressively overtook the CALR-mutant clone, extinguishing the ET phenotype as VEXAS features emerged (47).